Sulopenem FDA Approval Status
Last updated by Judith Stewart, BPharm on Dec 10, 2020.
FDA Approved: No
Generic name: sulopenem
Company: Iterum Therapeutics plc
Treatment for: Bacterial Infection
Sulopenem is an orally bioavailable, broad-spectrum penem β-lactam antibiotic in development for the treatment of infections caused by multi-drug resistant bacteria.
Development Timeline for sulopenem
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.